The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
Open accessAbstract
Pulmonary arterial hypertension (PAH) is a life-threatening disease that can be induced by dasatinib, a dual Src and BCR-ABL tyrosine kinase inhibitor that is used to treat chronic myelogenous leukemia (CML). Today, key questions remain regarding the mechanisms involved in the long-term development of dasatinib-induced PAH. Here, we demonstrated that chronic dasatinib therapy causes pulmonary endothelial damage in humans and rodents. We found that dasatinib treatment attenuated hypoxic pulmonary vasoconstriction responses and increased susceptibility to experimental pulmonary hypertension (PH) in rats, but these effects were absent in rats treated with imatinib, another BCR-ABL tyrosine kinase inhibitor. Furthermore, dasatinib treatment induced pulmonary endothelial cell apoptosis in a dose-dependent manner, while imatinib did not. Dasatinib treatment mediated endothelial cell dysfunction via increased production of ROS that was independent of Src family kinases. Consistent with these findings, we observed elevations in markers of endothelial dysfunction and vascular damage in the serum of CML patients who were treated with dasatinib, compared with CML patients treated with imatinib. Taken together, our findings indicate that dasatinib causes pulmonary vascular damage, induction of ER stress, and mitochondrial ROS production, which leads to increased susceptibility to PH development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationDruker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationReversal of experimental pulmonary hypertension by PDGF inhibition
Schermuly, R. T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24838 · Cited by 1,058
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research · doi:10.1161/circresaha.113.301141 · Cited by 1,029
Self-citationPulmonary Arterial Hypertension in Patients Treated by Dasatinib
Montani, D., Bergot, E., Günther, S., Savale, L., Bergeron, A., Bourdin, A., Bouvaist, H., Canuet, M., Pison, C., Macro, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.079921 · Cited by 659
Self-citationWeisberg, E., Manley, P. W., Cowan-Jacob, S. W., Hochhaus, A., & Griffin, J. D. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2126 · Cited by 636
Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension
Tuder, R. M., Archer, S. L., Dorfmüller, P., Erzurum, S. C., Guignabert, C., Michelakis, E., Rabinovitch, M., Schermuly, R., Stenmark, K. R., & Morrell, N. W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.025 · Cited by 585
Self-citationSelective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension
Long, L., Ormiston, M. L., Yang, X., Southwood, M., Gräf, S., Machado, R. D., Mueller, M., Kinzel, B., Yung, L. M., Wilkinson, J. M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3877 · Cited by 513
Intracellular K+ Suppresses the Activation of Apoptosis in Lymphocytes
Hughes, F. M., Bortner, C. D., Purdy, G. D., & Cidlowski, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30567 · Cited by 460
Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension
de Man, F. S., Tu, L., Handoko, M. L., Rain, S., Ruiter, G., François, C., Schalij, I., Dorfmüller, P., Simonneau, G., Fadel, E., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0411oc · Cited by 346
Self-citationEddahibi, S., Guignabert, C., Barlier-Mur, A.-M., Dewachter, L., Fadel, E., Dartevelle, P., Humbert, M., Simonneau, G., Hanoun, N., Saurini, F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.591321 · Cited by 297
Self-citationRicard, N., Tu, L., Le Hiress, M., Huertas, A., Phan, C., Thuillet, R., Sattler, C., Fadel, E., Seferian, A., Montani, D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007469 · Cited by 208
Self-citationPathogenesis of pulmonary arterial hypertension: lessons from cancer
Guignabert, C., Tu, L., Le Hiress, M., Ricard, N., Sattler, C., Seferian, A., Huertas, A., Humbert, M., & Montani, D. (2013) · European Respiratory Review · doi:10.1183/09059180.00007513 · Cited by 206
Self-citationLe Hiress, M., Tu, L., Ricard, N., Phan, C., Thuillet, R., Fadel, E., Dorfmüller, P., Montani, D., de Man, F., Humbert, M., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0322oc · Cited by 199
Self-citationPhysiological Concentrations of K+ Inhibit Cytochrome c-dependent Formation of the Apoptosome
Cain, K., Langlais, C., Sun, X.-M., Brown, D. G., & Cohen, G. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107419200 · Cited by 197
Huertas, A., Perros, F., Tu, L., Cohen-Kaminsky, S., Montani, D., Dorfmüller, P., Guignabert, C., & Humbert, M. (2014) · Circulation · doi:10.1161/circulationaha.113.004555 · Cited by 194
Self-citationK+-dependent Cerebellar Granule Neuron Apoptosis
Lauritzen, I., Zanzouri, M., Honoré, E., Duprat, F., Ehrengruber, M. U., Lazdunski, M., & Patel, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302631200 · Cited by 193
Kamath, A. V., Wang, J., Lee, F. Y., & Marathe, P. H. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0478-8 · Cited by 191
Bouchet, S., Chauzit, E., Ducint, D., Castaing, N., Canal-Raffin, M., Moore, N., Titier, K., & Molimard, M. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.02.023 · Cited by 176
Self-citationNew Molecular Targets of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
Guignabert, C., Tu, L., Girerd, B., Ricard, N., Huertas, A., Montani, D., & Humbert, M. (2015) · Chest · doi:10.1378/chest.14-0862 · Cited by 173
Self-citationTu, L., Dewachter, L., Gore, B., Fadel, É., Dartevelle, P., Simonneau, G., Humbert, M. J. C., Eddahibi, S., & Guignabert, C. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0317oc · Cited by 173
Self-citationEndoplasmic reticulum stress and endothelial dysfunction
Lenna, S., Han, R., & Trojanowska, M. (2014) · IUBMB Life · doi:10.1002/iub.1292 · Cited by 169
Oxygen sensing and signal transduction in hypoxic pulmonary vasoconstriction
Sommer, N., Strielkov, I. V., Pak, O., & Weißmann, N. (2015) · European Respiratory Journal · doi:10.1183/13993003.00945-2015 · Cited by 169
Attenuating Endoplasmic Reticulum Stress as a Novel Therapeutic Strategy in Pulmonary Hypertension
Dromparis, P., Paulin, R., Stenson, T. H., Haromy, A., Sutendra, G., & Michelakis, E. D. (2013) · Circulation · doi:10.1161/circulationaha.112.133413 · Cited by 167
Guignabert, C., Alvira, C. M., Alastalo, T., Sawada, H., Hansmann, G., Zhao, M., Wang, L., El‐Bizri, N., & Rabinovitch, M. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00199.2009 · Cited by 158
Self-citationDromparis, P., Paulin, R., Sutendra, G., Qi, A. C., Bonnet, S., & Michelakis, E. D. (2013) · Circulation Research · doi:10.1161/circresaha.112.300699 · Cited by 150
Pathology and Pathobiology of Pulmonary Hypertension
Guignabert, C., & Dorfmüller, P. (2013) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0033-1356496 · Cited by 144
Self-citationSrc tyrosine kinase is crucial for potassium channel function in human pulmonary arteries
Nagaraj, C., Tang, B., Bálint, Z., Wygrecka, M., Hrzenjak, A., Kwapiszewska, G., Stacher, E., Lindenmann, J., Weir, Ε. K., Olschewski, H., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00211811 · Cited by 107
Guignabert, C., Tu, L., Izikki, M., Dewachter, L., Zadigue, P., Humbert, M. J. C., Adnot, S., Fadel, É., & Eddahibi, S. (2009) · The FASEB Journal · doi:10.1096/fj.09-131664 · Cited by 101
Self-citationApoptosis recruits two-pore domain potassium channels used for homeostatic volume regulation
Trimarchi, J. R., Liu, L., Smith, P. J., & Keefe, D. L. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00365.2001 · Cited by 88
Shaker, M. E., Zalata, K. R., Mehal, W. Z., Shiha, G. E.-S., & Ibrahim, T. M. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.02.004 · Cited by 87
A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.
Tu, L., de Man, F. S., Girerd, B., Huertas, A., Chaumais, M., Lecerf, F., François, C., Perros, F., Dorfmüller, P., Fadel, E., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0309oc · Cited by 87
Self-citationOxidative stress is involved in Dasatinib-induced apoptosis in rat primary hepatocytes
Xue, T., Luo, P., Zhu, H., Zhao, Y., Wu, H., Gai, R., Wu, Y., Yang, B., Yang, X., & He, Q. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.04.010 · Cited by 75
Leptin signalling system as a target for pulmonary arterial hypertension therapy
Huertas, A., Tu, L., Thuillet, R., Hiress, M. L., Phan, C., Ricard, N., Nadaud, S., Fadel, É., Humbert, M. J. C., & Guignabert, C. (2015) · European Respiratory Journal · doi:10.1183/09031936.00193014 · Cited by 74
Self-citationWang, G., Wu, S., Xu, W., Jin, H. W., Zhu, Z., Li, Z., Tian, Y., Zhang, J., Rao, J.-J., & Wu, S. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.83 · Cited by 52
Blocking endothelial adhesion molecules: a potential therapeutic strategy to combat atherogenesis
Lutters, B. C. H., Leeuwenburgh, M. A., Appeldoorn, C. C. M., Molenaar, T. J. M., van Berkel, T. J. C., & Biessen, E. A. L. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200410000-00008 · Cited by 51
Kim, Y., Fiel, M. I., Albanis, E., Chou, H., Zhang, W., Khitrov, G., & Friedman, S. L. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02806.x · Cited by 41
Korashy, H. M., Rahman, A. F. M. M., & Kassem, M. G. (2014) · Profiles of drug substances, excipients, and related methodology · doi:10.1016/b978-0-12-800173-8.00004-0 · Cited by 37
Occlusive Lung Arterial Lesions in Endothelial-Targeted, Fas-Induced Apoptosis Transgenic Mice
Goldthorpe, H., Jiang, J.-Y., Taha, M., Deng, Y., Sinclair, T., Ge, C. X., Jurasz, P., Turksen, K., Mei, S. H. J., & Stewart, D. J. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0311oc · Cited by 36
Assessment of Endoplasmic Reticulum Stress and the Unfolded Protein Response in Endothelial Cells
Witte, I., & Horke, S. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-385116-1.00008-x · Cited by 28
Hachmane, M. F. E., Rees, K. A., Veale, E. L., Sumbayev, V. V., & Mathie, A. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.500033 · Cited by 10
Cited by
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Humbert, M., Guignabert, C., Bonnet, S., Dorfmüller, P., Klinger, J. R., Nicolls, M. R., Olschewski, A. J., Pullamsetti, S. S., Schermuly, R. T., Stenmark, K. R., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01887-2018 · Cited by 1,281
Self-citationon behalf of the Intensive Care in Hematological and Oncological Patients (iCHOP) Collaborative Group, Kroschinsky, F., Stölzel, F., von Bonin, S., Beutel, G., Kochanek, M., Kiehl, M., & Schellongowski, P. (2017) · Critical Care · doi:10.1186/s13054-017-1678-1 · Cited by 500
Novais, E. J., Tran, V. A., Johnston, S. N., Darris, K. R., Roupas, A. J., Sessions, G. A., Shapiro, I. M., Diekman, B. O., & Risbud, M. V. (2021) · Nature Communications · doi:10.1038/s41467-021-25453-2 · Cited by 440
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
Huertas, A., Montani, D., Savale, L., Pichon, J., Tu, L., Parent, F., Guignabert, C., & Humbert, M. (2020) · European Respiratory Journal · doi:10.1183/13993003.01634-2020 · Cited by 340
Self-citationOxidative Stress in Pulmonary Fibrosis
Otoupalova, E., Smith, S., Cheng, G., & Thannickal, V. J. (2020) · Comprehensive Physiology · doi:10.1002/cphy.c190017 · Cited by 262
Metadata
- Authors
- Guignabert, C., Phan, C., Seferian, A., Huertas, A., Tu, L., Thuillet, R., Sattler, C., Le Hiress, M., Tamura, Y., Jutant, E.-M., Chaumais, M.-C., Bouchet, S., Manéglier, B., Molimard, M., Rousselot, P., Sitbon, O., Simonneau, G., Montani, D., & Humbert, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2016-08-02
- Volume
- 126
- Issue
- 9
- Pages
- 3207-3218
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2496712281
- Cited by
- 276
- References
- 45
- FWCI
- 24.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.